Insider Stock Trading History of Nader Francois


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Nader Francois since year 2005. The trader's CIK number is 1365343. At the time of this reporting, Nader Francois is the President, CEO and Director of Nps Pharmaceuticals Inc . (stock ticker symbol NPSP). See this page for all insider trading activities at Nps Pharmaceuticals Inc .


Stock purchases, sales, and option exercises reported by insider Nader Francois since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2015-02-12 NPSP Nps Pharmaceuticals Inc Option Ex 43,804 10.61 464,935
2015-02-13 NPSP Nps Pharmaceuticals Inc Option Ex 24,301 .00 0
2014-02-13 NPSP Nps Pharmaceuticals Inc Option Ex 24,301 .00 0
2013-12-12 NPSP Nps Pharmaceuticals Inc Option Ex 139,116 4.61 641,602
2013-09-26 NPSP Nps Pharmaceuticals Inc Option Ex 20,342 5.45 110,863
2013-09-27 NPSP Nps Pharmaceuticals Inc Option Ex 43,458 5.91 256,706
2013-09-26 NPSP Nps Pharmaceuticals Inc Sale 150,000 33.34 5,000,250
2013-09-27 NPSP Nps Pharmaceuticals Inc Sale 43,458 32.36 1,406,127
2013-04-08 NPSP Nps Pharmaceuticals Inc Option Ex 150,000 4.48 671,700
2013-04-09 NPSP Nps Pharmaceuticals Inc Option Ex 150,000 4.04 606,450
2013-04-10 NPSP Nps Pharmaceuticals Inc Option Ex 128,985 3.60 463,959
2013-04-08 NPSP Nps Pharmaceuticals Inc Sale 150,000 11.00 1,650,750
2013-04-09 NPSP Nps Pharmaceuticals Inc Sale 150,000 11.27 1,689,900
2013-04-10 NPSP Nps Pharmaceuticals Inc Sale 148,367 11.68 1,732,481
2013-02-19 NPSP Nps Pharmaceuticals Inc Option Ex 50,000 .00 0
2011-11-09 NPSP Nps Pharmaceuticals Inc Buy 30,000 5.36 160,800
2010-02-03 NPSP Nps Pharmaceuticals Inc Sale 19,350 3.37 65,209
2009-10-17 NPSP Nps Pharmaceuticals Inc Option Ex 21,533 .00 0
2008-04-17 NPSP Nps Pharmaceuticals Inc Option Ex 21,534 .00 0

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Nader Francois (President, CEO and Director of Nps Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.